Pharmacogenetics: From Bench to Byte— An Update of Guidelines

@article{Swen2011PharmacogeneticsFB,
  title={Pharmacogenetics: From Bench to Byte— An Update of Guidelines},
  author={J. Swen and M. Nijenhuis and A. Boer and L. Grandia and A. Maitland‐van der Zee and H. Mulder and G. Rongen and R. Schaik and T. Schalekamp and D. Touw and J. Weide and B. Wilffert and V.H.M. Deneer and H. Guchelaar},
  journal={Clinical Pharmacology & Therapeutics},
  year={2011},
  volume={89}
}
  • J. Swen, M. Nijenhuis, +11 authors H. Guchelaar
  • Published 2011
  • Medicine
  • Clinical Pharmacology & Therapeutics
  • Currently, there are very few guidelines linking the results of pharmacogenetic tests to specific therapeutic recommendations. Therefore, the Royal Dutch Association for the Advancement of Pharmacy established the Pharmacogenetics Working Group with the objective of developing pharmacogenetics‐based therapeutic (dose) recommendations. After systematic review of the literature, recommendations were developed for 53 drugs associated with genes coding for CYP2D6, CYP2C19, CYP2C9, thiopurine‐S… CONTINUE READING
    707 Citations

    Topics from this paper

    Paper Mentions

    Blog Post
    Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update
    • 140
    • PDF
    Cytochrome P450 genotype‐guided drug therapies: An update on current states
    • 13
    Pharmacogenetics implementation in the clinics: information and guidelines for germline variants
    • 5
    • Highly Influenced
    • PDF
    Pharmacogenomics guidelines: Current status and future development
    • 1

    References

    SHOWING 1-10 OF 14 REFERENCES
    Pharmacogenetics: From Bench to Byte
    • 175
    • PDF
    Clinically Available Pharmacogenomics Tests
    • 64
    Role of warfarin pharmacogenetic testing in clinical practice.
    • 52
    • PDF
    Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.
    • 1,329
    • PDF
    Relative Impact of Genotype and Enzyme Induction on the Metabolic Capacity of CYP2C9 in Healthy Volunteers
    • 35